NeuroStorm Company Profile, Contacts & Intelligence

NeuroStorm Overview

NeuroStorm is developing Digital Medicines, particularly Software as a Medical Device (SaMD) technologies for parkinsonian tremor. We have developed and tested algorithms to eliminate tremors in Virtual Reality (VR). These algorithms enable Parkinson's patients (and members of other movement disorder populations) to function normally in VR. Additionally and importantly, this smart use of VR results in Parkinson's patients having less tremors in real life. We are working with healthcare providers to bring our technology to market as metaverse Software as a Medical Device (SaMD), an emerging segment of medicine (just approved by the FDA in 2021) so one day our technology will be prescribed by physicians just as would be done for a therapeutic pill or surgical instrument. See our latest publication: Algorithmic Virtual Reality Reduces Parkinsonian Tremor. Cornacchioli et al., medRxiv 2023. https://www.medrxiv.org/content/10.1101/2023.02.05.22283323v1 See our clinical trial (NCT05666674, 2023, Enrolling by invitation): https://clinicaltrials.gov/ct2/show/NCT05666674

Headquarters

1412 Broadway, 21st Floor

Website

neurostorm.studio

Industry

Hospitals And Health Care

Founded

2019

NAICS

Health Care and Social Assistance, Social Assistance

Company Email

Available in AeroLeads

NeuroStorm Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

NeuroStorm People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Compare Similar Companies to NeuroStorm

Explore companies in related markets and compare their industry and employee estimates.